CMS releases guidance for Medicare Drug Price Negotiation Program that it expects to revise by summer

The Centers for Medicare and Medicaid Services on Wednesday released the parameters for the first year of prescription drug negotiations to lower prices in Medicare. 

The negotiations will affect only Medicare Part D for the first two years, for ten drugs during the first year and 15 in the second year, CMS said.

After that, Part B gets included.

The first year the negotiated prices will apply is 2026.

Read the full post on News Feed